CITIC Capital
CITIC Capital, FountainVest buy control of pallet leasing business
CITIC Capital Partners and FountainVest Partners have acquired a majority stake in China Merchants Loscam, a pallet and packaging business owned by Sinotrans, for RMB2.48 billion ($359 million).
PE-backed AsiaInfo raises $115m in Hong Kong IPO
AsiaInfo Technologies, a Chinese telecom software provider that was privatized by a CITIC Capital-led consortium in 2014, has raised HK$899.3 million ($115 million) in its Hong Kong IPO.
CITIC Capital buys control of cooking sauce brand Amoy
CITIC Capital has acquired a controlling stake in Amoy Food, a Hong Kong-based manufacturer of cooking sauces owned by Japanese food and beverage maker Ajinomoto, for an undisclosed sum.
GPs need industry networks to source China buyouts - AVCJ Forum
Private equity firms should establish deep connections within target industries if they are to take advantage of China's emerging buyout opportunity, industry participants told the AVCJ Forum.
China PE outlook: End of the party
Growth stage technology deals have retained a strong following in 2018, but elsewhere in Chinese private equity the mood is more somber
CITIC Capital buys Japan's Nippon Oil Pump from Wendel
CITIC Capital Partners has agreed to acquire Nippon Oil Pump (NOP), a Japan-based maker of hydraulic pumps and motors, from European listed investment firm Wendel for about EUR85 million ($97 million).
Deal focus: Linklogis embraces supply chain finance 2.0
GIC Private leads $220 million investment in Linklogis, a financial technology player aiming to fill China's supply chain finance gap
GIC leads $220m Series C for China supply chain finance player
Chinese supply chain finance provider Linklogis has raised $220 million in a Series C round of funding led by GIC Private.
Chinese corporate-PE partnerships: Meeting of minds
Collaborative deals between private equity firms and Chinese strategic players reflects the more diverse range of corporates seeking outbound deals - and also a recognition among GPs that they need help growing newly-acquired assets in China
China credit services specialist WeShare gets $90m Series B
Shenzhen-based Chinese financial services provider WeShare has secured $90 million in Series B funding led by Huaxing Growth Capital, an investment arm of China Renaissance, as well as CITIC Capital and Loyal Valley Capital.
CITIC Capital hits $1.3b first close on new China fund
CITIC Capital has reached a first close of $1.3 billion on its latest US dollar-denominated China fund, which has an overall target of $2 billion.
GPs support $590m investment in take-private target China Biologic
China Biologic Products, a US-listed biopharmaceuticals player that was subject to two take-private offers, said it was set to raise $590 million by issuing new shares to investors including Centurium Capital, CITIC Capital, and Hillhouse Capital.
China facilities management: Cleaning up
Private equity investors are turning their attention to China’s outsourced facilities management market, recognizing the opportunities presented by under-penetration and fragmentation
China's PE-backed AsiaInfo files for HK IPO
AsiaInfo Technologies, a Chinese telecommunications software provider backed by a number of private equity firms, has filed for a Hong Kong IPO.
Asia exits have 'never been easier,' GPs say - AVCJ Forum
Private equity exits in Asia are on a roll, driven by rising Chinese strategic interest and the emergence of larger pan-regional private equity firms looking for secondary buyouts, industry participants told the AVCJ USA Forum.
China-US trade: Balance of power
A long-smoldering trade dispute between the US and China has begun to reverberate globally across a range of sectors. Private equity must not ignore the potential impacts
CITIC Capital makes $3.6b bid for China Biologic Products
CITIC Capital has submitted a take-private bid for China Biologic Products that values the US-listed biopharmaceutical developer at approximately $3.65 billion.
CITIC Capital invests China-Europe logistics providers
CITIC Capital has backed two China-Europe logistics providers in separate deals of undisclosed size. The GP is investing via its Silk Road Fund, which targets geographies in China’s One Belt One Road (OBOR) agenda.
Deal focus: CITIC backs China geothermal energy player
Investing in Icelandic geothermal energy required a certain level of creative thinking from CITIC Capital and China Everbright. But their partner, Artic Green Energy, is already making a difference in China's polluted cities
Asian investors commit $150m to Arctic Green Energy
CITIC Capital and China Everbright have committed $100 million in debt and equity funding to Iceland-based geothermal energy developer Arctic Green Energy (AGE), alongside a $50 million loan facility provided by the Asian Development Bank (ADB).
CITIC Capital acquires Chinese facility management service provider
China-focused GP CITIC Capital Partners has acquired a majority stake in Jiangsu Sky Facility Management (SkyFM), a Chinese facility management service provider, for an undisclosed sum.
China investors eye carve-out opportunities
Private equity investors continue to look overseas for control deals that have a China angle, but they expect to see greater domestic activity too as multinationals divest China operations in the face of a challenging operating environment.
China buyouts: Responsible owners
From privatizations to succession planning to corporate carve-outs, China-focused GPs are seeing an increasing number of control buyout opportunities. But are they positioned to take full advantage?
CITIC Capital-backed Harbin Pharma buys 40% stake in GNC
China’s Harbin Pharmaceutical Group, which is controlled by CITIC Capital, has agreed to acquire a 40% stake in GNC Holdings for $300 million, becoming the largest shareholder in the US-based nutritional supplements retailer.